PRLAX | SLARX | PRLAX / SLARX | |
Total Expense Ratio | 1.46 | 1.18 | 124% |
Annual Report Gross Expense Ratio | 1.46 | 1.33 | 110% |
Fund Existence | 32 years | 11 years | - |
Gain YTD | 27.665 | 34.074 | 81% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 374M | 281M | 133% |
Annual Yield % from dividends | 2.98 | 4.23 | 70% |
Returns for 1 year | 2.67 | 9.48 | 28% |
Returns for 3 years | 18.10 | 24.46 | 74% |
Returns for 5 years | 26.28 | 50.52 | 52% |
Returns for 10 years | 37.11 | 132.84 | 28% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
REPIX | 40.98 | 0.40 | +0.99% |
ProFunds Real Estate UltraSector Inv | |||
FBTAX | 30.03 | 0.26 | +0.87% |
Fidelity Advisor Biotechnology A | |||
FIJZX | 54.15 | -0.13 | -0.24% |
Fidelity Advisor Consumer Discret Z | |||
PWCIX | 88.75 | -0.23 | -0.26% |
Principal Capital Appreciation Inst | |||
TMITX | 11.34 | -0.06 | -0.53% |
Transamerica Mid Cap Growth I3 |